v3.24.4
Equity Awards (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Information About Outstanding And Vested Stock Options
A summary of stock option activity for the year ended December 31, 2024 was as follows:
Number of
Shares 		Weighted-
Average
Exercise
Price Per Share		Weighted-
Average
Remaining
Contractual
Term 		Aggregate
Intrinsic Value
(in thousands)(in years)(in millions)
Outstanding as of December 31, 20231,150 $603.30 
Exercised(74)$324.80 $35 
Forfeited(128)$645.02 
Outstanding as of December 31, 2024948 $619.43 6.6$418 
Vested and expected to vest as of December 31, 2024878 $614.17 6.5$391 
Vested and exercisable as of December 31, 2024444 $545.37 6.2$229 
Restricted Stock Unit Table
A summary of RSU activity for the year ended December 31, 2024 was as follows:
Number of
Shares 		Weighted-Average Grant-Date Fair Value Per Share
(in thousands)
Outstanding as of December 31, 20236,262 $506.77 
Granted3,031 $791.14 
Vested(2,944)$545.45 
Forfeited(561)$567.81 
Outstanding as of December 31, 20245,788 $630.10 
Expected to vest as of December 31, 20245,233 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The following assumptions were used in the Black-Scholes options pricing model and the Monte Carlo simulation model, to estimate our stock-based compensation on the date of grant for ESPP, stock options and PRSUs, respectively, as applicable.
 Year Ended December 31,
202420232022
Risk-Free Interest Rate
ESPP
4.96% - 5.39%
2.96% - 5.39%
0.06% - 2.96%
Stock Options**
2.04%
PRSU
3.97% - 4.56%
4.34%
1.76%
Expected Term (in years)
ESPP0.50.50.5
Stock Options
*
*
10
Expected Volatility
ESPP
25% - 40%
33% - 59%
35% - 59%
Stock Options**
40%
PRSU
33% - 42%
45%
42%
* There were no stock option grants in 2024 and 2023.